1
40
2
-
Hyperlink
A link, or reference, to another resource on the Internet.
URL
https://doi.org/10.1093/ajhp/zxab426
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Key articles and guidelines for the pediatric clinical pharmacist from 2019 and 2020
Creator
An entity primarily responsible for making the resource
Kelly S Bobo
M Petrea Cober
Lea S Eiland
Melissa Heigham
Morgan King
Peter N Johnson
Jamie L Miller
Caroline M Sierra
Date
A point or period of time associated with an event in the lifecycle of the resource
2022
Description
An account of the resource
Purpose: To summarize recently published research reports and practice guidelines deemed to be significantly impactful for pediatric pharmacy practice.
Summary: Our author group was composed of 8 board-certified pediatric pharmacists. Eight major themes were identified: critical care, hematology/oncology, medication safety, general pediatrics, infectious diseases, neurology/psychiatry, gastrointestinal/nutrition, and neonatology. The author group was assigned a specific theme(s) based on their practice expertise and were asked to identify articles using MEDLINE and/or searches of relevant journal articles pertaining to each theme that were published from January 2019 through December 2020 that they felt were "significant" for pediatric pharmacy practice. A final list of compiled articles was distributed to the authors, and an article was considered significant if it received a vote from 5 of the 8 authors. Thirty-two articles, including 16 clinical practice guidelines or position statements and 16 review or primary literature articles, were included in this review. For each of these articles, a narrative regarding its implications for pediatric pharmacy practice is provided.
Conclusion: Given the heterogeneity of pediatric patients, it is difficult for pediatric pharmacists to stay up to date with the most recent literature, especially in practice areas outside their main expertise. Over the last few years, there has been a significant number of publications impacting the practice of pediatric pharmacists. This review of articles that have significantly affected pediatric pharmacy practice may be helpful in staying up to date on key articles in the literature.
Source
A related resource from which the described resource is derived
Am J Health Syst Pharm
. 2022 Feb 18;79(5):364-384. doi: 10.1093/ajhp/zxab426.
Language
A language of the resource
English
2022
Critical Care
Infectious Diseases
medication safety
neonates
nutrition
pediatrics.
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1016/j.jstrokecerebrovasdis.2017.09.066" target="_blank" rel="noreferrer noopener">http://doi.org/10.1016/j.jstrokecerebrovasdis.2017.09.066</a>
Pages
e48–e49
Issue
3
Volume
27
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Safe Readministration of Intravenous Thrombolysis in Recurrent Basilar Thrombosis.
Publisher
An entity responsible for making the resource available
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Date
A point or period of time associated with an event in the lifecycle of the resource
2018
2018-03
Subject
The topic of the resource
Aged; Basilar Artery; Basilar Artery – Drug Effects; Basilar Artery – Physiopathology; Basilar Artery/diagnostic imaging/*drug effects/physiopathology; Cerebral Angiography – Methods; Cerebral Angiography/methods; Computed Tomography Angiography; Drug Administration Schedule; Fibrinolytic Agents – Administration and Dosage; Fibrinolytic Agents – Adverse Effects; Fibrinolytic Agents/*administration & dosage/adverse effects; Humans; Infusions; Intracranial Thrombosis; Intracranial Thrombosis – Drug Therapy; Intracranial Thrombosis – Physiopathology; Intracranial Thrombosis/diagnostic imaging/*drug therapy/physiopathology; Intravenous; Magnetic Resonance Imaging; Male; medication safety; Recombinant Proteins – Administration and Dosage; Recombinant Proteins/administration & dosage; Recurrence; recurrent stroke; Repeat Procedures; Retreatment; thrombolysis; Thrombolytic Therapy – Adverse Effects; Thrombolytic Therapy – Methods; Thrombolytic Therapy/adverse effects/*methods; Thrombosis; Time Factors; Tissue Plasminogen Activator – Administration and Dosage; Tissue Plasminogen Activator – Adverse Effects; Tissue Plasminogen Activator/*administration & dosage/adverse effects; Treatment Outcome; Treatment Outcomes
Creator
An entity primarily responsible for making the resource
Khan Alina; Itrat Ahmed
Description
An account of the resource
We report a patient who had recurrence of stroke in the basilar artery territory because of repeat thrombosis, and was administered intravenous recombinant tissue plasminogen activator (IV-rtPA) twice within a span of 3 weeks without any adverse events, with radiological evidence of successful thrombolysis. Because of minor and improving stroke symptoms with IV-rtPA, endovascular therapy was not performed and there was radiological evidence of recanalization with IV-rtPA alone. This report adds to the very limited literature on the topic demonstrating safe and successful use of repeat IV thrombolysis following a previous recent stroke.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1016/j.jstrokecerebrovasdis.2017.09.066" target="_blank" rel="noreferrer noopener">10.1016/j.jstrokecerebrovasdis.2017.09.066</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2018
Aged
Basilar Artery
Basilar Artery – Drug Effects
Basilar Artery – Physiopathology
Basilar Artery/diagnostic imaging/*drug effects/physiopathology
Cerebral Angiography – Methods
Cerebral Angiography/methods
Computed Tomography Angiography
Department of Internal Medicine
Drug Administration Schedule
Fibrinolytic Agents – Administration and Dosage
Fibrinolytic Agents – Adverse Effects
Fibrinolytic Agents/*administration & dosage/adverse effects
Humans
Infusions
Intracranial Thrombosis
Intracranial Thrombosis – Drug Therapy
Intracranial Thrombosis – Physiopathology
Intracranial Thrombosis/diagnostic imaging/*drug therapy/physiopathology
Intravenous
Itrat Ahmed
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Khan Alina
Magnetic Resonance Imaging
Male
medication safety
NEOMED College of Medicine
Recombinant Proteins – Administration and Dosage
Recombinant Proteins/administration & dosage
Recurrence
recurrent stroke
Repeat Procedures
Retreatment
thrombolysis
Thrombolytic Therapy – Adverse Effects
Thrombolytic Therapy – Methods
Thrombolytic Therapy/adverse effects/*methods
Thrombosis
Time Factors
Tissue Plasminogen Activator – Administration and Dosage
Tissue Plasminogen Activator – Adverse Effects
Tissue Plasminogen Activator/*administration & dosage/adverse effects
Treatment Outcome
Treatment Outcomes